Evolution of pharmacokinetics and pharmacokinetic/dynamic correlations during the 20th century

被引：15

作者：

Hochhaus, G

Barrett, JS

Derendorf, H

机构：

[1] Univ Florida, Coll Pharm, Gainesville, FL 32610 USA

[2] Dupont Merck Pharmaceut Co, Newark, DE USA

来源：

JOURNAL OF CLINICAL PHARMACOLOGY | 2000年 / 40卷 / 09期

关键词：

D O I：

10.1177/00912700022009648

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

[No abstract available]

引用

页码：908 / 917

页数：10

共 144 条

[1]

AARONS L, 1991, BRIT J CLIN PHARMACO, V32, P669

[2]

[Anonymous], MOL PHARM MODE ACTIO

[3]

[Anonymous], PHARMACOKINETIC PHAR

[4] Application of pharmacodynamic modeling for designing time-variant dosing regimens to overcome nitroglycerin tolerance in experimental heart failure [J].

Bauer, JA ;

Balthasar, JP ;

Fung, HL .

PHARMACEUTICAL RESEARCH, 1997, 14 (09) :1140-1145

[5]

BEAL SL, 1982, CRIT REV BIOMED ENG, V8, P195

[6] POPULATION PHARMACOKINETIC DATA AND PARAMETER-ESTIMATION BASED ON THEIR 1ST 2 STATISTICAL MOMENTS .1. [J].

BEAL, SL .

DRUG METABOLISM REVIEWS, 1984, 15 (1-2) :173-193

[7]

Beal SL, 1980, NONMEM USERS GUIDE 1

[8] URINARY EXCRETION KINETICS OF AMPHETAMINE IN MAN [J].

BECKETT, AH ;

ROWLAND, M .

JOURNAL OF PHARMACY AND PHARMACOLOGY, 1965, 17 (10) :628-&

[9]

BENET L, 1976, EFFECT DIS STATE PHA

[10] GENERAL TREATMENT OF LINEAR MAMMILLARY MODELS WITH ELIMINATION FROM ANY COMPARTMENT AS USED IN PHARMACOKINETICS [J].

BENET, LZ .

JOURNAL OF PHARMACEUTICAL SCIENCES, 1972, 61 (04) :536-&

← 1 2 3 4 5 6 7 8 9 10 →